Clozaril

Clozaril or clozapine, one of first new drugs designed for treating schizophrenia in over 20 years, was introduced in 1975 (1989 in United States) by Novartis Pharmaceuticals Corporation and is mostly used in Europe. Symptoms such as hallucinations, delusions, blunted affect, and hostility are successfully addressed with this synthesized antipsychotic pharmaceutical, which is also marketed as leponex.